![Jonathan M. Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan M.
Kaye is currently an investor at Cohen Asset Management, Inc., Medmen Properties LLC, and Beliade.
Previously, he worked as an investor at Bryn Pharma LLC.
| Sociétés | Poste | Début |
|---|---|---|
Beliade Consumer Partners
 Beliade Consumer Partners Investment ManagersFinance Beliade Consumer Partner invests in companies located in the United States with revenues of USD 1 - 5 million. The firm targets companies operating in the fields of consumer and retail sectors. It provides financing for debt and equity for seed, early and growth stage capital requirements. The firm also makes co-investments and participates in follow-on rounds. | Private Equity Investor | 01/01/2018 |
Medmen Properties LLC | Private Equity Investor | 01/01/2017 |
Cohen Asset Management, Inc.
 Cohen Asset Management, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment firm | Private Equity Investor | 01/01/1998 |
| Sociétés | Poste | Fin |
|---|---|---|
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Analyste en capital-investissement | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Cohen Asset Management, Inc.
Cohen Asset Management, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment firm | Finance |
Medmen Properties LLC | |
Beliade Consumer Partners
Beliade Consumer Partners Investment ManagersFinance Beliade Consumer Partner invests in companies located in the United States with revenues of USD 1 - 5 million. The firm targets companies operating in the fields of consumer and retail sectors. It provides financing for debt and equity for seed, early and growth stage capital requirements. The firm also makes co-investments and participates in follow-on rounds. | Finance |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
